Herpes simplex viruses: is a vaccine tenable?
Open Access
- 15 July 2002
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 110 (2) , 145-151
- https://doi.org/10.1172/jci16126
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatomaGene Therapy, 2002
- Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukinsGene Therapy, 1998
- A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 DiseaseThe Journal of Infectious Diseases, 1997
- Gene Transfer into Experimental Brain Tumors Mediated by Adenovirus, Herpes Simplex Virus, and Retrovirus VectorsHuman Gene Therapy, 1994
- Vaccination with Recombinant Herpes Simplex Virus Glycoproteins: Protection Against Initial and Recurrent Genital HerpesThe Journal of Infectious Diseases, 1987
- Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus‐specific glycoproteins gB or gDJournal of Medical Virology, 1985
- Infectious vaccinia virus recombinants that express hepatitis B virus surface antigenNature, 1983
- Efficacy of a nucleic acid free herpetic subunit vaccineArchiv für die gesamte Virusforschung, 1980
- STUDIES ON HERPES SIMPLEX VIRUS VI. OBSERVATIONS ON PATIENTS WITH RECURRENT HERPETIC LESIONS INJECTED WITH HERPES VIRUSES OR THEIR ANTIGENSThe Lancet Healthy Longevity, 1955